⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5101921 | 0.50 | — | — | |
| SCHEMBL1450836 | 0.48 | — | — | |
| SCHEMBL5464130 | 0.48 | — | — | |
| SCHEMBL3066105 | 0.42 | — | — | |
| SCHEMBL561897 | 0.34 | — | — | |
| SCHEMBL138192 | 0.34 | — | — | |
| Ammonia Solution, Strong SCHEMBL30436342 | 0.29 | — | — | |
| SCHEMBL31091685 | 0.29 | — | — | |
| SCHEMBL4895995 | 0.25 | — | — | |
| SCHEMBL7579781 | 0.25 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2083 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230312522-A1 | CYP46A1 INHIBITORS AND METHODS OF USE THEREOF | SAGE THERAPEUTICS, INC. | 2023-10-05 | — | — | US | claimed |
| EP-4251618-A1 | 4-FLUORO-(4-(4-BENZYL)PIPERIDIN-1-YL)(2-(PYRIMIDIN-4-YL)PYRIDIN-3-YL)METHANONE DERIVATIVES AND SIMILAR COMPOUNDS AS CYP46A1 INHIBITORS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS | Sage Therapeutics, Inc. (US) | 2023-10-04 | — | — | EP | claimed |
| CN-116235315-A | Additive, lithium secondary battery electrolyte comprising same, and lithium secondary battery | 三星SDI株式会社 | 2023-06-06 | — | — | CN | claimed |
| WO-2022115620-A1 | 4-FLUORO-(4-(4-BENZYL)PIPERIDIN-1-YL)(2-(PYRIMIDIN-4-YL)PYRIDIN-3-YL)METHANONE DERIVATIVES AND SIMILAR COMPOUNDS AS CYP46A1 INHIBITORS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS | SAGE THERAPEUTICS, INC. (US) | 2022-06-02 | — | — | WO | claimed |
| WO-2022115521-A1 | (HETEO)ARYL SUBSTITUTED PYRROLO-, PYRAZOLO- AND TRIAZOLOPYRIDAZINE DERIVATES AS MAT2A INHIBITORS | SERVIER PHARMACEUTICALS, LLC (US) | 2022-06-02 | — | — | WO | claimed |
| WO-2020243027-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS OF USE | SAGE THERAPEUTICS, INC. (US) | 2020-12-03 | — | — | WO | claimed |
| CN-110938845-A | Plating solution for electrolytic tinning | 上村工业株式会社 | 2020-03-31 | — | — | CN | claimed |
| US-20150119319-A1 | MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS | ABBVIE INC. | 2015-04-30 | — | — | US | claimed |
| EP-1827423-B1 | NOVEL CYCLIC UREAS USED AS INHIBITORS OF METALLOPROTEASES | SANOFI AVENTIS DEUTSCHLAND (DE) | 2010-06-30 | — | — | EP | claimed |
| US-20090269313-A1 | ENCAPSULATION SYSTEM | DIAKINE THERAPEUTICS, INC. (US) | 2009-10-29 | — | — | US | claimed |
| WO-2004055003-A1 | 2-SUBSTITUTED QUINAZOLIN-4-YLAMINE ANALOGUES AS CAPSAICIN RECEPTOR MODULATORS | NEUROGEN CORPORATION (US) | 2004-07-01 | — | — | WO | claimed |
| US-20030203888-A1 | Chromophores | WELLCOME TRUST LIMITED, THE (GB) | 2003-10-30 | — | — | US | claimed |
| EP-1294726-A2 | IMPROVEMENTS IN AND RELATING TO CHROMOPHORES | Catalyst Biomedica Ltd (GB) | 2003-03-26 | — | — | EP | claimed |
| US-20020169203-A1 | Ion channel modulating agents | NEUROSEARCH A/S (DK) | 2002-11-14 | — | — | US | claimed |
| WO-2002000662-A1 | IMPROVEMENTS IN AND RELATING TO CHROMOPHORES | CATALYST BIOMEDICA LIMITED (GB) | 2002-01-03 | — | — | WO | claimed |
| EP-1140784-A2 | ION CHANNEL MODULATING AGENTS | NEUROSEARCH A/S (DK) | 2001-10-10 | — | — | EP | claimed |
| WO-2000037422-A2 | ION CHANNEL MODULATING AGENTS | NEUROSEARCH A/S (DK) | 2000-06-29 | — | — | WO | claimed |
| US-5532332-A | METHINE LINKAGES | WEAVER MAX A (US) | 1996-07-02 | — | — | US | claimed |
| US-5376650-A | Colorants for thermoplastic resins | EASTMAN CHEMICAL COMPANY (US) | 1994-12-27 | — | — | US | claimed |
| US-5254625-A | Blends of a thermoplastic resin and a polymeric methine dye; molding materials; heat resistance; low volatility; nonextractable; brightness; nontoxic | EASTMAN KODAK COMPANY (US) | 1993-10-19 | — | — | US | claimed |